Demystifying Fogging in Lyophilized Products: Impact of Pharmaceutical Processing

被引:0
|
作者
Kaur, Navpreet [1 ]
More, Apurva [2 ]
Mckeeby, Jacob [3 ]
Vanipenta, Ragaleena [1 ]
Patel, Fenil [4 ]
Kish, Mary [1 ]
Pelekoudas, Dimitrios [5 ]
Piquenot, Alexandre [6 ]
Nakach, Mostafa [7 ]
Mccoy, Timothy R. [8 ]
Fontana, Lauren [1 ]
Saluja, Atul [9 ]
机构
[1] Sanofi, Biol Drug Prod Dev, Framingham, MA 01701 USA
[2] Takeda, Drug Prod Dev, Lexington, MA 02421 USA
[3] Vertex Pharmaceut, Boston, MA 02210 USA
[4] HitchBio Inc, Harvard Pagliuca Life Lab, Boston, MA 02134 USA
[5] Sanofi, Genom Med Unit, Waltham, MA USA
[6] Refact, Lille, Hauts De France, France
[7] Sanofi R&D, 1 Impasse Ateliers, F-94403 Vitry Sur Seine, France
[8] Amgen Inc, Waterford, Ireland
[9] Sanofi, MSAT, Framingham, MA 01701 USA
关键词
Fogging; Marangoni flow; Lyophilization; Process; Formulation development; Primary packaging;
D O I
10.1016/j.xphs.2024.03.021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A commonly encountered challenge with freeze-dried drug products is glass vial fogging. Fogging is characterized by a thin layer of product deposited upon the inner surface of the vial above the lyophilized cake. While considered to be a routine cosmetic defect in many instances, fogging around the shoulder and neck of the vial may potentially impact container closure integrity and reject rates during inspection. In this work, the influence of processing conditions i.e. vial pre-treatment, lyophilization cycle modifications and filling conditions on fogging was evaluated. A battery of analytical techniques was employed to investigate factors affecting glass vial fogging. A fogging score was used to quantify its severity in freeze-dried products. Additionally, a dye-based method was used to study solution upcreep (Marangoni flow) following product filling. Our lab-scale results indicate measurable improvement in fogging following the addition of an annealing step in the lyophilization cycle. Pre-freeze isothermal holding of the vials (at 5 degrees C on the lyophilizer shelf) for an extended duration indicated a reduction in fogging whereas an increase in the freezing time exhibited no effect on fogging. Vial pre-treatment conditions were critical determinants of fogging for Type 1 vials whereas they had no impact on fogging in TopLyo (R) (R) vials. The headspace relative humidity (RH) investigation also indicated sufficient increase in the water vapor pressure inside the vial to be conducive to the formulation of a hydration film- the precursor to Marangoni flow. (c) 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2305 / 2313
页数:9
相关论文
共 50 条